248 related articles for article (PubMed ID: 8917278)
1. Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase.
Hiraoka Y; Kishimoto C; Takada H; Nakamura M; Kurokawa M; Ochiai H; Shiraki K
J Am Coll Cardiol; 1996 Nov; 28(6):1610-5. PubMed ID: 8917278
[TBL] [Abstract][Full Text] [Related]
2. Low-dose N omega-nitro-L-arginine methyl ester treatment improves survival rate and decreases myocardial injury in a murine model of viral myocarditis induced by coxsackievirus B3.
Mikami S; Kawashima S; Kanazawa K; Hirata K; Hotta H; Hayashi Y; Itoh H; Yokoyama M
Circ Res; 1997 Oct; 81(4):504-11. PubMed ID: 9314831
[TBL] [Abstract][Full Text] [Related]
3. Oral L-arginine prevents murine coxsackievirus B3 myocarditis.
Takada H; Kishimoto C; Hiraoka Y; Ochiai H
Int J Cardiol; 2002 Dec; 86(2-3):273-9. PubMed ID: 12419566
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.
Zell R; Markgraf R; Schmidtke M; Görlach M; Stelzner A; Henke A; Sigusch HH; Glück B
Med Microbiol Immunol; 2004 May; 193(2-3):91-100. PubMed ID: 14513374
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide inhibits viral replication in murine myocarditis.
Lowenstein CJ; Hill SL; Lafond-Walker A; Wu J; Allen G; Landavere M; Rose NR; Herskowitz A
J Clin Invest; 1996 Apr; 97(8):1837-43. PubMed ID: 8621766
[TBL] [Abstract][Full Text] [Related]
6. Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3.
Mikami S; Kawashima S; Kanazawa K; Hirata K; Katayama Y; Hotta H; Hayashi Y; Ito H; Yokoyama M
Biochem Biophys Res Commun; 1996 Mar; 220(3):983-9. PubMed ID: 8607880
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors.
Jadeski LC; Lala PK
Am J Pathol; 1999 Oct; 155(4):1381-90. PubMed ID: 10514420
[TBL] [Abstract][Full Text] [Related]
8. Involvement of nitric oxide in neuroglycopenia-induced insulin and glucagon secretion in the mouse.
Ahrén B; Karlsson S; Scheurink AJ; Steffens AB
Eur J Pharmacol; 1995 Jun; 280(1):27-35. PubMed ID: 7498251
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
10. Heme oxygenase-1 mediates oxidative stress and apoptosis in coxsackievirus B3-induced myocarditis.
Ursu ON; Sauter M; Ettischer N; Kandolf R; Klingel K
Cell Physiol Biochem; 2014; 33(1):52-66. PubMed ID: 24401606
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of inducible nitric oxide synthase in murine myocardium infected with wildtype or attenuated Coxsackievirus B3.
Zhang H; Bevan A; Inniss H; Archard LC; Robinson NM; Debelder A; Martin JF; Charles IG; Moncada S
Biochem Soc Trans; 1997 Aug; 25(3):415S. PubMed ID: 9388645
[No Abstract] [Full Text] [Related]
12. Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction.
Eriksson U; Kurrer MO; Bingisser R; Eugster HP; Saremaslani P; Follath F; Marsch S; Widmer U
Circulation; 2001 Jan; 103(1):18-21. PubMed ID: 11136679
[TBL] [Abstract][Full Text] [Related]
13. Cerebral metabolic recovery from deep hypothermic circulatory arrest after treatment with arginine and nitro-arginine methyl ester.
Hiramatsu T; Jonas RA; Miura T; duPlessis A; Tanji M; Forbess JM; Holtzman D
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):698-707. PubMed ID: 8800158
[TBL] [Abstract][Full Text] [Related]
14. Effects of the nitric oxide synthase inhibitors N(G)-nitro-L-arginine methyl ester and aminoethyl-isothiourea on the liver microcirculation in rat endotoxemia.
Corso CO; Gundersen Y; Dörger M; Lilleaasen P; Aasen AO; Messmer K
J Hepatol; 1998 Jan; 28(1):61-9. PubMed ID: 9537865
[TBL] [Abstract][Full Text] [Related]
15.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
16. Effects of nitric oxide inhibition on the spread of biotinylated dextran and on extracellular space parameters in the neostriatum of the male rat.
Jansson A; Mazel T; Andbjer B; Rosén L; Guidolin D; Zoli M; Syková E; Agnati LF; Fuxe K
Neuroscience; 1999; 91(1):69-80. PubMed ID: 10336061
[TBL] [Abstract][Full Text] [Related]
17. Expression of inducible nitric oxide synthase in experimental viral myocarditis.
Glück B; Merkle I; Dornberger G; Stelzner A
Herz; 2000 May; 25(3):255-60. PubMed ID: 10904848
[TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice.
Yamada K; Hiramatsu M; Noda Y; Mamiya T; Murai M; Kameyama T; Komori Y; Nikai T; Sugihara H; Nabeshima T
Neuroscience; 1996 Sep; 74(2):365-74. PubMed ID: 8865189
[TBL] [Abstract][Full Text] [Related]
19. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
[TBL] [Abstract][Full Text] [Related]
20. Further studies on anti- and proconvulsant effects of inhibitors of nitric oxide synthase in rodents.
Alexander CB; Ellmore TM; Kokate TG; Kirkby RD
Eur J Pharmacol; 1998 Feb; 344(1):15-25. PubMed ID: 9570442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
